Samsara Insider Sold Shares Worth $641,913, According to a Recent SEC Filing-September 2024-www.financetom.com

Samsara Insider Sold Shares Worth $641,913, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Samsara Insider Sold Shares Worth $641,913, According to a Recent SEC Filing

Jun 12, 2024 3:03 PM

05:57 PM EDT, 06/12/2024 (MT Newswires) -- Dominic Phillips, Executive Vice President, Chief Financial Officer, on June 10, 2024, sold 21,053 shares in Samsara (IOT) for $641,913. Following the Form 4 filing with the SEC, Phillips has control over a total of 2,199,805 shares of the company, with 1,137,989 shares held directly and 1,061,816 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1642896/000141588924016539/xslF345X03/form4-06122024_090609.xml

Price: 29.42, Change: +0.01, Percent Change: +0.03

Previous page： Form 8.3 Next page： Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3

Nov 17, 2025

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing

Nov 17, 2025

BRISTOL, Tenn., Nov. 17, 2025 /PRNewswire/ -- Kingsway Pharmaceuticals, a U.S.-based consumer healthcare company specializing in nationally distributed OTC brands and private label solutions, announced today that it has acquired a strategic minority stake in CIGA Healthcare, a global diagnostics innovator supplying rapid tests and home diagnostic technologies to more than 70 countries. The investment forms a joint venture alignment...

Form 8.3

Nov 17, 2025

Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million

Nov 17, 2025

Inflection Point and investors increase PIPE commitments to more than $200 million, including over $85 million of pre-funded PIPE capital BOSTON--(BUSINESS WIRE)-- Merlin Labs, Inc. (“Merlin”), a leading developer of assured, autonomous flight technology for defense customers, and Inflection Point Acquisition Corp. IV ( BACQ ) (“Inflection Point”) today announced a significant increase to their previously disclosed private investment...